Evidence map›Paper›PMID 20172362›Full record

ReviewSeminars in oncology2010

Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic framework.

Andrew J Vickers, Angel M Cronin

Abstract readReview
In one paragraph

Review in Seminars in oncology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Multigene panels in prostate cancer risk assessment: a systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2016
    Pooled it
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Diabetes Study of Children of Diverse Ethnicity and Race: Study design.Diabetes/metabolism research and reviews · 2024
    Observational
  15. Review
  16. Article
  17. Article
  18. Decision Curve Analysis for Personalized Treatment Choice between Multiple Options.Medical decision making : an international journal of the Society for Medical Decision Making · 2023
    Article
  19. Article
  20. A Framework for Using Real-World Data and Health Outcomes Modeling to Evaluate Machine Learning-Based Risk Prediction Models.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andrew J VickersDepartment of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. vickersa@mskcc.org
Angel M Cronin

Funding

SPORE In Prostate CancerP50CA092629 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI JAMES A EASTHAM · 2001 to 2026
$63.0M
NCI NIH HHS P50 CA092629NCI NIH HHS P50-CA92629
6 · The paper itself

Abstract

Cancer prediction models are becoming ubiquitous, yet we generally have no idea whether they do more good than harm. This is because current statistical methods for evaluating prediction models are uninformative as to their clinical value. Prediction models are typically evaluated in terms of discrimination or calibration. However, it is generally unclear how high discrimination needs to be before it is considered "high enough"; similarly, there are no rational guidelines as to the degree of miscalibration that would discount clinical use of a model. Classification tables do present the results of models in more clinically relevant terms, but it is not always clear which of two models is preferable on the basis of a particular classification table, or even whether either model should be used at all. Recent years have seen the development of straightforward decision analytic techniques that evaluate prediction models in terms of their consequences. This depends on the simple approach of weighting true and false positives differently, to reflect that, for example, delaying the diagnosis of a cancer is more harmful than an unnecessary biopsy. Such decision analytic techniques hold the promise of determining whether clinical implementation of prediction models would do more good than harm.

Indexed as

Decision Support TechniquesModels, StatisticalArea Under CurveCalibrationHumansNeoplasmsRisk

Identifiers

PMID20172362
PMCPMC2857322

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.